RESMED INC — Director's Dealing 2021

Nov 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2021-11-11

Reporting Person: Douglas Robert Andrew (President and COO ResMed Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-11	ResMed Common Stock	F	945	$259.47	Disposed	21266	Direct
2021-11-15	ResMed Common Stock	M	8000	$58.24	Acquired	29266	Direct
2021-11-15	ResMed Common Stock	S	8000	$271.75	Disposed	21266	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-15	ResMed Common Stock Options	$58.24	M	8000	Disposed	2022-11-19	ResMed Common Stock (8000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	210407	Indirect

Footnotes

F1: Disposition to issuer for tax withholding on scheduled vesting of Restricted Stock Units granted 11/19/2020.

F2: Includes 62.8289 shares of ResMed stock purchased on October 29, 2021, through the ResMed Employee Stock Purchase Plan.

F3: The transaction was conducted under a Rule 10b5-1 plan.

F4: Represents date options first became exercisable. Options vest 1/3 per year.